An Updated Review on the Metabolite (AM404)-Mediated Central Mechanism of Action of Paracetamol (Acetaminophen): Experimental Evidence and Potential Clinical Impact

References

• Nagakura Y. The need for fundamental reforms in the pain research field to develop innovative drugs. Expert Opin Drug Discov. 2017;12(1):39–46. doi:10.1080/17460441.2017.1261108
   PubMed Web of Science ®Google Scholar
• Ennis ZN, Dideriksen D, Vægter HB, Handberg G, Pottegård A. Acetaminophen for chronic pain: a systematic review on efficacy. Basic Clin Pharmacol Toxicol. 2016;118(3):184–189. doi:10.1111/BCPT.12527
   PubMed Web of Science ®Google Scholar
• O’Neil CK, Hanlon JT, Marcum ZA. Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics. Am J Geriatr Pharmacother. 2012;10(6):331–342. doi:10.1016/j.amjopharm.2012.09.004
   PubMedGoogle Scholar
• Mallet C, Eschalier A. The rediscovery of paracetamol, In: Farquhar-Smith P, Beaulieu P, Jaggar S, editors. Landmark Papers in Pain: Seminal Papers in Pain with Expert Commentaries. Vol. 1. 1st ed. Oxford University Press; 2018. doi:10.1093/MED/9780198834359.003.0004
   Google Scholar
• Freo U, Ruocco C, Valerio A, Scagnol I, Nisoli E. Paracetamol: a review of guideline recommendations. J Clin Med. 2021;10(15). doi:10.3390/jcm10153420
   PubMedGoogle Scholar
• Alchin J, Dhar A, Siddiqui K, Christo PJ. Why paracetamol (Acetaminophen) is a suitable first choice for treating mild to moderate acute pain in adults with liver, kidney or cardiovascular disease, gastrointestinal disorders, asthma, or who are older. Curr Med Res Opin. 2022;1–15. doi:10.1080/03007995.2022.2049551
   Google Scholar
• Bertolini A, Ferrari A, Ottani A, Guerzoni S, Tacchi R, Leone S. Paracetamol: new vistas of an old drug. CNS Drug Rev. 2006;12(3–4):250–275. doi:10.1111/j.1527-3458.2006.00250.x
   PubMedGoogle Scholar
• Flower RJ, Vane JR. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature. 1972;240(5381):410–411. doi:10.1038/240410A0
   PubMed Web of Science ®Google Scholar
• Esh CJ, Chrismas BCR, Mauger AR, Taylor L. Pharmacological hypotheses: is Acetaminophen selective in its cyclooxygenase inhibition? Pharmacol Res Perspect. 2021;9(4):e00835. doi:10.1002/prp2.835
   PubMed Web of Science ®Google Scholar
• Ohashi N, Kohno T. Analgesic effect of acetaminophen: a review of known and novel mechanisms of action. Front Pharmacol. 2020;11:580289. doi:10.3389/fphar.2020.580289
   PubMed Web of Science ®Google Scholar
• Przybyła GW, Szychowski KA, Gmiński J. Paracetamol - An old drug with new mechanisms of action. Clin Exp Pharmacol Physiol. 2020. doi:10.1111/1440-1681.13392
   PubMedGoogle Scholar
• Mallet C, Eschalier A, Daulhac L. Paracetamol: update on its analgesic mechanism of action. Pain Reli. 2017. doi:10.5772/66649
   Google Scholar
• Graham GG, Davies MJ, Day RO, Mohamudally A, Scott KF. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 2013;21(3):201–232. doi:10.1007/s10787-013-0172-x
   PubMed Web of Science ®Google Scholar
• Toussaint K, Yang XC, Zielinski MA, et al. What do we (not) know about how paracetamol (acetaminophen) works? J Clin Pharm Ther. 2010;35(6):617–638. doi:10.1111/J.1365-2710.2009.01143.X
   PubMed Web of Science ®Google Scholar
• Raffa RB, Walker EA, Sterious SN. Opioid receptors and acetaminophen (paracetamol). Eur J Pharmacol. 2004;503(1–3):209–210. doi:10.1016/j.ejphar.2004.08.055
   PubMedGoogle Scholar
• Högestätt ED, Jönsson BAG, Ermund A, et al. Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system*. J Biol Chem. 2005;280(36):31405–31412. doi:10.1074/JBC.M501489200
   PubMed Web of Science ®Google Scholar
• Mallet C, Daulhac L, Bonnefont J, et al. Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia. Pain. 2008;139(1):190–200. doi:10.1016/J.PAIN.2008.03.030
   PubMed Web of Science ®Google Scholar
• Barrière DA, Mallet C, Blomgren A, et al. Fatty acid amide hydrolase-dependent generation of antinociceptive drug metabolites acting on TRPV1 in the brain. PLoS One. 2013;8(8). doi:10.1371/JOURNAL.PONE.0070690
   PubMedGoogle Scholar
• Dalmann R, Daulhac L, Antri M, Eschalier A, Mallet C. Supra-spinal FAAH is required for the analgesic action of paracetamol in an inflammatory context. Neuropharmacology. 2015;91:63–70. doi:10.1016/J.NEUROPHARM.2014.11.006
   PubMedGoogle Scholar
• Muramatsu S, Shiraishi S, Miyano K, et al. Metabolism of AM404 From Acetaminophen at Human Therapeutic Dosages in the Rat Brain. Anesthesiol Pain Med. 2016;6(1). doi:10.5812/AAPM.32873
   PubMedGoogle Scholar
• Saliba SW, Marcotegui AR, Fortwängler E, et al. AM404, paracetamol metabolite, prevents prostaglandin synthesis in activated microglia by inhibiting COX activity. J Neuroinflammation. 2017;14(1). doi:10.1186/S12974-017-1014-3
   Google Scholar
• Sodano F, Lazzarato L, Rolando B, et al. Paracetamol-galactose conjugate: a novel prodrug for an old analgesic drug. Mol Pharm. 2019;16(10):4181–4189. doi:10.1021/acs.molpharmaceut.9b00508
   PubMedGoogle Scholar
• Parashar A. Pharmacological screening of glycine amino acid prodrug of acetaminophen. Indian J Pharmacol. 2015;47(2):202–205. doi:10.4103/0253-7613.153431
   PubMedGoogle Scholar
• Wu Z, Patel A, Dave R, Yuan X. Development of acetaminophen proline prodrug. Bioorg Med Chem Lett. 2010;20(13):3851–3854. doi:10.1016/J.BMCL.2010.05.050
   PubMedGoogle Scholar
• Fadl TA, Omar FA. Paracetamol (acetaminophen) esters of some non-steroidal anti-inflammatory carboxylic acids as mutual prodrugs with improved therapeutic index. Inflammopharmacology. 1998;6(2):143–157. doi:10.1007/S10787-998-0031-3
   PubMedGoogle Scholar
• Hanel AM, Lands WEM. Modification of anti-inflammatory drug effectiveness by ambient lipid peroxides. Biochem Pharmacol. 1982;31(20):3307–3311. doi:10.1016/0006-2952(82)90565-2
   PubMedGoogle Scholar
• Schildknecht S, Daiber A, Ghisla S, Cohen RA, Bachschmid MM. Acetaminophen inhibits prostanoid synthesis by scavenging the PGHS-activator peroxynitrite. FASEB J. 2008;22(1):215–224. doi:10.1096/FJ.06-8015COM
   PubMedGoogle Scholar
• Ouellet M, Percival MD. Mechanism of acetaminophen inhibition of cyclooxygenase isoforms. Arch Biochem Biophys. 2001;387(2):273–280. doi:10.1006/ABBI.2000.2232
   PubMed Web of Science ®Google Scholar
• Lucas R, Warner TD, Vojnovic I, Mitchell JA, Mitchell JA. Cellular mechanisms of acetaminophen: role of cyclo-oxygenase. FASEB J. 2005;19(6):1–15. doi:10.1096/FJ.04-2437FJE
   PubMedGoogle Scholar
• Boutaud O, Aronoff DM, Richardson JH, Marnett LJ, Oates JA. Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H2 synthases. Proc Natl Acad Sci U S A. 2002;99(10):7130–7135. doi:10.1073/PNAS.102588199/ASSET/682AB754-3CF6-4EC9-B4FB-18483C903C21/ASSETS/GRAPHIC/PQ1025881008.JPEG
   PubMed Web of Science ®Google Scholar
• Graham GG, Scott KF. Mechanism of action of paracetamol. Am J Ther. 2005;12(1):46–55.
   PubMedGoogle Scholar
• Aronoff DM, Oates JA, Boutaud O. New insights into the mechanism of action of acetaminophen: its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases. Clin Pharmacol Ther. 2006;79(1):9–19. doi:10.1016/j.clpt.2005.09.009
   PubMed Web of Science ®Google Scholar
• Murakami M, Naraba H, Tanioka T, et al. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem. 2000;275(42):32783–32792. doi:10.1074/JBC.M003505200
   PubMed Web of Science ®Google Scholar
• Chandrasekharan NV, Dai H, Roos KLT, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A. 2002;99(21):13926–13931. doi:10.1073/pnas.162468699
   PubMed Web of Science ®Google Scholar
• Schwab JM, Beiter T, Linder JU, et al. COX-3--A virtual pain target in humans? FASEB J. 2003;17(15):2174–2175. doi:10.1096/FJ.03-0595LTE
   PubMedGoogle Scholar
• Dinchuk JE, Liu RQ, Trzaskos JM. COX-3: in the wrong frame in mind. Immunol Lett. 2003;86(1):121. doi:10.1016/S0165-2478(02)00268-7
   PubMedGoogle Scholar
• Mallet C, Barrière DA, Ermund A, et al. TRPV1 in brain is involved in acetaminophen-induced antinociception. PLoS One. 2010;5(9):1–11. doi:10.1371/journal.pone.0012748
   Google Scholar
• Ayoub SS. Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action. Temperature. 2021;8(4): 351–371. doi:10.1080/23328940.2021.1886392
   Google Scholar
• Engström Ruud L, Wilhelms DB, Eskilsson A, et al. Acetaminophen reduces lipopolysaccharide-induced fever by inhibiting cyclooxygenase-2. Neuropharmacology. 2013;71:124–129. doi:10.1016/J.NEUROPHARM.2013.03.012
   PubMedGoogle Scholar
• Feldberg W, Gupta KP. Pyrogen fever and prostaglandin-like activity in cerebrospinal fluid. J Physiol. 1973;228(1):41–53. doi:10.1113/JPHYSIOL.1973.SP010071
   PubMed Web of Science ®Google Scholar
• Ayoub SS, Botting RM, Goorha S, Colville-Nash PR, Willoughby DA, Ballou LR. Acetaminophen-induced hypothermia in mice is mediated by a prostaglandin endoperoxide synthase 1 gene-derived protein. Proc Natl Acad Sci U S A. 2004;101(30):11165–11169. doi:10.1073/PNAS.0404185101
   PubMedGoogle Scholar
• Mirrasekhian E, Nilsson JLÅ, Shionoya K, et al. The antipyretic effect of paracetamol occurs independent of transient receptor potential ankyrin 1-mediated hypothermia and is associated with prostaglandin inhibition in the brain. FASEB J. 2018;32(10):5751–5759. doi:10.1096/fj.201800272R
   PubMed Web of Science ®Google Scholar
• Sharma CV, Long JH, Shah S, et al. First evidence of the conversion of paracetamol to AM404 in human cerebrospinal fluid. J Pain Res. 2017;10:2703–2709. doi:10.2147/JPR.S143500
   PubMed Web of Science ®Google Scholar
• Rastogi P, Anderson SJ, Bear HD, et al. Preoperative chemotherapy: updates of national surgical adjuvant breast and bowel project protocols B-18 and B-27. J Clin Oncol. 2008;26(5):778–785. doi:10.1200/JCO.2007.15.0235
   PubMed Web of Science ®Google Scholar
• Kerckhove N, Mallet C, François A, et al. Ca(v)3.2 calcium channels: the key protagonist in the supraspinal effect of paracetamol. Pain. 2014;155(4):764–772. doi:10.1016/J.PAIN.2014.01.015
   PubMed Web of Science ®Google Scholar
• Ohashi N, Uta D, Sasaki M, Ohashi M, Kamiya Y, Kohno T. Acetaminophen metabolite N-acylphenolamine induces analgesia via transient receptor potential vanilloid 1 receptors expressed on the primary afferent terminals of C-fibers in the spinal dorsal horn. Anesthesiology. 2017;127(2):355–371. doi:10.1097/ALN.0000000000001700
   PubMedGoogle Scholar
• Ryskamp DA, Redmon S, Jo AO, Križaj D. TRPV1 and endocannabinoids: emerging molecular signals that modulate mammalian vision. Cells. 2014;3(3):914. doi:10.3390/CELLS3030914
   PubMedGoogle Scholar
• Liao HT, Lee HJ, Ho YC, Chiou LC. Capsaicin in the periaqueductal gray induces analgesia via metabotropic glutamate receptor-mediated endocannabinoid retrograde disinhibition. Br J Pharmacol. 2011;163(2):330. doi:10.1111/J.1476-5381.2011.01214.X
   PubMedGoogle Scholar
• Zygmunt PM, Chuang HH, Movahed P, Julius D, Högestätt ED. The anandamide transport inhibitor AM404 activates vanilloid receptors. Eur J Pharmacol. 2000;396:1. 39–42. doi:10.1016/S0014-2999(00)00207-7
   PubMed Web of Science ®Google Scholar
• Barrière DA, Boumezbeur F, Dalmann R, et al. Paracetamol is a centrally acting analgesic using mechanisms located in the periaqueductal grey. Br J Pharmacol. 2020;177(8):1773–1792. doi:10.1111/bph.14934
   PubMedGoogle Scholar
• Pickering G, Creveaux I, Macian N, Pereira B. Paracetamol and pain modulation by TRPV1, UGT2B15, SULT1A1 genotypes: a randomized clinical trial in healthy volunteers. Pain Med. 2020;21(4):661–669. doi:10.1093/PM/PNZ037
   PubMed Web of Science ®Google Scholar
• Bourinet E, Francois A, Laffray S. T-type calcium channels in neuropathic pain. Pain. 2016;157:S15–S22. doi:10.1097/J.PAIN.0000000000000469
   PubMedGoogle Scholar
• Harding EK, Zamponi GW. Central and peripheral contributions of T-type calcium channels in pain. Mol Brain. 2022;15(1):1–13. doi:10.1186/S13041-022-00923-W
   PubMedGoogle Scholar
• Francois A, Kerckhove N, Meleine M, et al. State-dependent properties of a new T-type calcium channel blocker enhance Ca(V)3.2 selectivity and support analgesic effects. Pain. 2013;154(2):283–293. doi:10.1016/J.PAIN.2012.10.023
   PubMedGoogle Scholar
• Barbara G, Alloui A, Nargeot J, et al. T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids. J Neurosci. 2009;29(42):13106–13114. doi:10.1523/JNEUROSCI.2919-09.2009
   PubMedGoogle Scholar
• Ottani A, Leone S, Sandrini M, Ferrari A, Bertolini A. The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors. Eur J Pharmacol. 2006;531(1–3):280–281. doi:10.1016/J.EJPHAR.2005.12.015
   PubMed Web of Science ®Google Scholar
• Hama AT, Sagen J. Cannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain. Neuropharmacology. 2010;58(4–5):758–766. doi:10.1016/J.NEUROPHARM.2009.12.010
   PubMedGoogle Scholar
• Heinricher MM, Tavares I, Leith JL, Lumb BM. Descending control of nociception: specificity, recruitment and plasticity. Brain Res Rev. 2009;60(1):214–225. doi:10.1016/j.brainresrev.2008.12.009
   PubMedGoogle Scholar
• Tjølsen A, Lund A, Hole K. Antinociceptive effect of paracetamol in rats is partly dependent on spinal serotonergic systems. Eur J Pharmacol. 1991;193(2):193–201. doi:10.1016/0014-2999(91)90036-P
   PubMed Web of Science ®Google Scholar
• Dogrul A, Seyrek M, Akgul EO, Cayci T, Kahraman S, Bolay H. Systemic paracetamol-induced analgesic and antihyperalgesic effects through activation of descending serotonergic pathways involving spinal 5-HT 7 receptors. Eur J Pharmacol. 2012;677(1–3):93–101. doi:10.1016/j.ejphar.2011.12.016
   PubMed Web of Science ®Google Scholar
• Courade JP, Caussade F, Martin K, et al. Effects of Acetaminophen on monoaminergic systems in the rat central nervous system. Naunyn Schmiedebergs Arch Pharmacol. 2001;364(6):534–537. doi:10.1007/s002100100484
   PubMedGoogle Scholar
• Pickering G, Loriot MA, Libert F, Eschalier A, Beaune P, Dubray C. Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism. Clin Pharmacol Ther. 2006;79(4):371–378. doi:10.1016/J.CLPT.2005.12.307
   PubMed Web of Science ®Google Scholar
• Nakamura S, Nonaka T, Komatsu S, Yamada T, Yamamoto T. Oral Acetaminophen-induced spinal 5-hydroxytryptamine release produces analgesic effects in the rat formalin test. Biomed Pharmacother. 2022;146. doi:10.1016/J.BIOPHA.2021.112578
   Google Scholar
• Alloui A, Pelissier T, Dubray C, Lavarenne J, Eschalier A. Tropisetron inhibits the antinociceptive effect of intrathecally administered paracetamol and serotonin. Fundam Clin Pharmacol. 1996;10(4):406–407. doi:10.1111/J.1472-8206.1996.TB00593.X
   PubMedGoogle Scholar
• Alloui A, Chassaing C, Schmidt J, et al. Paracetamol exerts a spinal, tropisetron-reversible, antinociceptive effect in an inflammatory pain model in rats. Eur J Pharmacol. 2002;443(1–3):71–77. doi:10.1016/S0014-2999(02)01578-9
   PubMed Web of Science ®Google Scholar
• Bonnefont J, Alloui A, Chapuy E, Clottes E, Eschalier A. Orally administered paracetamol does not act locally in the rat formalin test: evidence for a supraspinal, serotonin-dependent antinociceptive mechanism. Anesthesiology. 2003;99(4):976–981. doi:10.1097/00000542-200310000-00034
   PubMed Web of Science ®Google Scholar
• Bonnefont J, Chapuy E, Clottes E, Alloui A, Eschalier A. Spinal 5-HT1A receptors differentially influence nociceptive processing according to the nature of the noxious stimulus in rats: effect of WAY-100635 on the antinociceptive activities of paracetamol, venlafaxine and 5-HT. Pain. 2005;114(3):482–490. doi:10.1016/J.PAIN.2005.01.019
   PubMed Web of Science ®Google Scholar
• Bonnefont J, Daulhac L, Etienne M, et al. Acetaminophen recruits spinal p42/p44 MAPKs and GH/IGF-1 receptors to produce analgesia via the serotonergic system. Mol Pharmacol. 2007;71(2):407–415. doi:10.1124/MOL.106.025775
   PubMedGoogle Scholar
• Liu J, Reid AR, Sawynok J. Antinociception by systemically-administered acetaminophen (paracetamol) involves spinal serotonin 5-HT7 and adenosine A1 receptors, as well as peripheral adenosine A1 receptors. Neurosci Lett. 2013;536(1):64–68. doi:10.1016/J.NEULET.2012.12.052
   PubMedGoogle Scholar
• Pickering G, Estève V, Loriot MA, Eschalier A, Dubray C. Acetaminophen reinforces descending inhibitory pain pathways. Clin Pharmacol Ther. 2008;84(1):47–51. doi:10.1038/SJ.CLPT.6100403
   PubMed Web of Science ®Google Scholar
• Yamaguchi C, Yamamoto D, Fujimaru Y, Asano T, Takaoka A. Acetaminophen exerts an analgesic effect on muscular hyperalgesia in repeated cold-stressed rats through the enhancement of the descending pain inhibitory system involving spinal 5-HT 3 and noradrenergic α 2 receptors. Biol Pharm Bull. 2021;44(8):1067–1074. doi:10.1248/BPB.B21-00178
   PubMedGoogle Scholar
• Pickering G, Faure M, Commun F, et al. Tropisetron and paracetamol association in post-operative patients. Fundam Clin Pharmacol. 2012;26(3):432–437. doi:10.1111/J.1472-8206.2011.00933.X
   PubMedGoogle Scholar
• Bandschapp O, Filitz J, Urwyler A, Koppert W, Ruppen W. Tropisetron blocks analgesic action of acetaminophen: a human pain model study. Pain. 2011;152(6):1304–1310. doi:10.1016/J.PAIN.2011.02.003
   PubMedGoogle Scholar
• Hamurtekin Y, Nouilati A, Demirbatir C, Hamurtekin E. The contribution of serotonergic receptors and nitric oxide systems in the analgesic effect of acetaminophen: an overview of the last decade. Turkish J Pharm Sci. 2020;17(1):119. doi:10.4274/TJPS.GALENOS.2018.35403
   PubMedGoogle Scholar
• Danelich IM, Wright SS, Lose JM, Tefft BJ, Cicci JD, Reed BN. Safety of nonsteroidal antiinflammatory drugs in patients with cardiovascular disease. Pharmacother J Hum Pharmacol Drug Ther. 2015;35(5):520–535. doi:10.1002/PHAR.1584
   Google Scholar
• Jozwiak-Bebenista M, Nowak JZ. Paracetamol: mechanism of action, applications and safety concern. Acta Pol Pharm Drug Res. 2014;71(1):11–23.
   PubMed Web of Science ®Google Scholar
• Hayward KL, Powell EE, Irvine KM, Martin JH. Can paracetamol (Acetaminophen) be administered to patients with liver impairment? Br J Clin Pharmacol. 2016;81(2):210–222. doi:10.1111/bcp.12802
   PubMed Web of Science ®Google Scholar
• Richette P, Doherty M, Pascual E, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76(1):29–42. doi:10.1136/annrheumdis-2016-209707
   PubMed Web of Science ®Google Scholar
• Haag G, Diener HC, May A, et al. Self-medication of migraine and tension-type headache: summary of the evidence-based recommendations of the Deutsche Migräne und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft für Neurologie (DGN), the Österreichische Kopfschmerzgesellschaft (Ö). J Headache Pain. 2011;12(2):201–217. doi:10.1007/s10194-010-0266-4
   PubMed Web of Science ®Google Scholar
• Gaul C, Eschalier A. Dose can help to achieve effective pain relief for acute mild to moderate pain with over-the-counter paracetamol. Open Pain J. 2018;11(1):12–20. doi:10.2174/1876386301811010012
   Google Scholar
• Perrot S, Eschalier A, Desmeules J, Lanteri-Minet M, Attal N. Practice guidelines for the treatment of acute migraine and chronic knee osteoarthritis with paracetamol: an expert appraisal on evolution over time between scientific societies. Curr Med Res Opin. 2022. doi:10.1080/03007995.2022.2076475
   PubMedGoogle Scholar
• McQuay HJ, Moore RA. Dose-response in direct comparisons of different doses of aspirin, ibuprofen and paracetamol (acetaminophen) in analgesic studies. Br J Clin Pharmacol. 2007;63(3):271–278. doi:10.1111/j.1365-2125.2006.02723.x
   PubMed Web of Science ®Google Scholar
• Piguet V, Desmeules J, Dayer P. Lack of Acetaminophen ceiling effect on R-III nociceptive flexion reflex. Eur J Clin Pharmacol. 1998;53(5):321–324. doi:10.1007/S002280050386
   PubMedGoogle Scholar
• Moore RA, Wiffen PJ, Derry S, Maguire T, Roy YM, Tyrrell L. Non-prescription (OTC) oral analgesics for acute pain - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2015;2017(10). doi:10.1002/14651858.CD010794.pub2
   Google Scholar
• Qi DS, May LG, Zimmerman B, et al. A randomized, double-blind, placebo-controlled study of acetaminophen 1000 mg versus acetaminophen 650 mg for the treatment of postsurgical dental pain. Clin Ther. 2012;34(12). doi:10.1016/j.clinthera.2012.11.003
   PubMedGoogle Scholar
• Evke S, Lin Q, Melendez JA, Begley TJ. Epitranscriptomic reprogramming is required to prevent stress and damage from Acetaminophen. Genes. 2022;13(3). doi:10.3390/GENES13030421/S1
   PubMedGoogle Scholar
• Bessede A, Marabelle A, Guégan JP, et al. Impact of Acetaminophen on the efficacy of immunotherapy in cancer patients. Ann Oncol off J Eur Soc Med Oncol. 2022;33(9):909–915. doi:10.1016/J.ANNONC.2022.05.010
   PubMedGoogle Scholar
• Davison SN. Clinical pharmacology considerations in pain management in patients with advanced kidney failure. Clin J Am Soc Nephrol. 2019;14(6):917–931. doi:10.2215/CJN.05180418
   PubMed Web of Science ®Google Scholar
• Hiragi S, Yamada H, Tsukamoto T, et al. Acetaminophen administration and the risk of acute kidney injury: a self-controlled case series study. Clin Epidemiol. 2018;10:265–276. doi:10.2147/CLEP.S158110
   PubMed Web of Science ®Google Scholar
• Evans M, Fored CM, Bellocco R, et al. Acetaminophen, aspirin and progression of advanced chronic kidney disease. Nephrol Dial Transplant. 2009;24(6):1908–1918. doi:10.1093/ndt/gfn745
   PubMed Web of Science ®Google Scholar
• Graham G, Graham R, Day R. Comparative analgesia, cardiovascular and renal effects of celecoxib, rofecoxib and acetaminophen (paracetamol). Curr Pharm Des. 2005;8(12):1063–1075. doi:10.2174/1381612023394917
   Google Scholar
• Davison SN, Rathwell S, George C, Hussain ST, Grundy K, Dennett L. Analgesic use in patients with advanced chronic kidney disease: a systematic review and meta-analysis. Can J Kidney Heal Dis. 2020;(7). doi:10.1177/2054358120910329
   Google Scholar
• Martín Arias LH, Martín González A, Sanz Fadrique R, Vazquez ES. Cardiovascular risk of nonsteroidal anti-inflammatory drugs and classical and selective cyclooxygenase-2 inhibitors: a meta-analysis of observational studies. J Clin Pharmacol. 2019;59(1):55–73. doi:10.1002/JCPH.1302
   PubMedGoogle Scholar
• White WB, Kloner RA, Angiolillo DJ, Davidson MH. Cardiorenal Safety of OTC Analgesics. J Cardiovasc Pharmacol Ther. 2018;23(2):103–118. doi:10.1177/1074248417751070
   PubMed Web of Science ®Google Scholar
• Dawson J, Fulton R, Mcinnes GT, et al. Acetaminophen use and change in blood pressure in a hypertensive population. J Hypertens. 2013;31(7):1485–1490. doi:10.1097/HJH.0b013e328360f6f8
   PubMed Web of Science ®Google Scholar
• Fulton RL, Walters MR, Morton R, et al. Acetaminophen use and risk of myocardial infarction and stroke in a hypertensive cohort. Hypertension. 2015;65(5):1008–1014. doi:10.1161/HYPERTENSIONAHA.114.04945
   PubMed Web of Science ®Google Scholar
• Turtle EJ, Dear JW, Webb DJ. A systematic review of the effect of paracetamol on blood pressure in hypertensive and non-hypertensive subjects. Br J Clin Pharmacol. 2013;75(6):1396–1405. doi:10.1111/BCP.12032
   PubMed Web of Science ®Google Scholar
• MacIntyre IM, Turtle EJ, Farrah TE, Graham C, Dear JW, Webb DJ. Regular acetaminophen use and blood pressure in people with hypertension: the PATH-BP trial. Circulation. 2022;145(6):416–423. doi:10.1161/CIRCULATIONAHA.121.056015
   PubMed Web of Science ®Google Scholar
• Schjerning AM, McGettigan P, Gislason G. Cardiovascular effects and safety of (non-aspirin) NSAIDs. Nat Rev Cardiol. 2020;17(9):574–584. doi:10.1038/s41569-020-0366-z
   PubMed Web of Science ®Google Scholar
• Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation. 2007;115(12):1634–1642. doi:10.1161/CIRCULATIONAHA.106.181424
   PubMed Web of Science ®Google Scholar
• Ishitsuka Y, Kondo Y, Kadowaki D. Toxicological property of acetaminophen: the dark side of a safe antipyretic/analgesic drug? Biol Pharm Bull. 2020;43(2):195–206. doi:10.1248/bpb.b19-00722
   PubMed Web of Science ®Google Scholar
• BMJ Publishing Group Limited. What dose of paracetamol for older people? Drug Ther Bull. 2018;56(6):69–72. doi:10.1136/dtb.2018.6.0636
   PubMedGoogle Scholar
• Wu CL, Raja SN. Treatment of acute postoperative pain. Lancet. 2011;377(9784):2215–2225. doi:10.1016/S0140-6736(11)60245-6
   PubMed Web of Science ®Google Scholar
• Raffa RB. Pharmacology of oral combination analgesics: rational therapy for pain. J Clin Pharm Ther. 2001;26(4):257–264. doi:10.1046/j.1365-2710.2001.00355.x
   PubMed Web of Science ®Google Scholar
• Patel R, Dickenson AH. Neuropharmacological basis for multimodal analgesia in chronic pain. Postgrad Med. 2022;134(3):245–259. doi:10.1080/00325481.2021.1985351
   PubMed Web of Science ®Google Scholar
• Gilron I, Jensen TS, Dickenson AH. Combination pharmacotherapy for management of chronic pain: from bench to bedside. Lancet Neurol. 2013;12(11):1084–1095. doi:10.1016/S1474-4422(13)70193-5
   PubMed Web of Science ®Google Scholar
• Bannwarth B, Péhourcq F. [Pharmacologic basis for using paracetamol: pharmacokinetic and pharmacodynamic issues]. Drugs. 2003;63(Special Issue 2):5–13. French. doi:10.2165/00003495-200363992-00003
   PubMedGoogle Scholar
• Schug SA. Combination analgesia in 2005—a rational approach: focus on paracetamol–tramadol. Clin Rheumatol. 2006;25(SUPPL 7):16–21. doi:10.1007/S10067-006-0202-9/FIGURES/5
   PubMedGoogle Scholar
• Dhillon S. Tramadol/paracetamol fixed-dose combination: a review of its use in the management of moderate to severe pain. Clin Drug Investig. 2010;30(10):711–738. doi:10.2165/11205830-000000000-00000
   PubMed Web of Science ®Google Scholar
• Jebaraj B, Maitra S, Baidya DK, Khanna P. Intravenous paracetamol reduces postoperative opioid consumption after orthopedic surgery: a systematic review of clinical trials. Pain Res Treat. 2013;2013. doi:10.1155/2013/402510
   Google Scholar
• Freo U. Paracetamol for multimodal analgesia. Pain Manag. 2022;12(6):737–750. doi:10.2217/pmt-2021-0116
   PubMed Web of Science ®Google Scholar
• Liu J, Di J, Zhang Y, Xing E. Oxycodone–paracetamol tablet exhibits increased analgesic efficacy for acute postoperative pain, higher satisfaction and comparable safety profiles compared with celecoxib in patients underwent arthroscopic knee surgery. Inflammopharmacology. 2021;29(4):1091–1099. doi:10.1007/s10787-021-00828-5
   PubMedGoogle Scholar
• Dahl JB, Nielsen RV, Wetterslev J, et al. Post-operative analgesic effects of paracetamol, NSAIDs, glucocorticoids, gabapentinoids and their combinations: a topical review. Acta Anaesthesiol Scand. 2014;58(10):1165–1181. doi:10.1111/AAS.12382
   PubMed Web of Science ®Google Scholar
• Miranda HF, Puig MM, Prieto JC, Pinardi G. Synergism between paracetamol and nonsteroidal anti-inflammatory drugs in experimental acute pain. Pain. 2006;121(1–2):22–28. doi:10.1016/J.PAIN.2005.11.012
   PubMedGoogle Scholar
• Ong CKS, Seymour RA, Lirk P, Merry AF. Combining paracetamol (acetaminophen) with nonsteroidal antiinflammatory drugs: a qualitative systematic review of analgesic efficacy for acute postoperative pain. Anesth Analg. 2010;110(4):1170–1179. doi:10.1213/ANE.0B013E3181CF9281
   PubMed Web of Science ®Google Scholar
• Moore RA, Derry CJ, Derry S, Straube S, McQuay HJ. A conservative method of testing whether combination analgesics produce additive or synergistic effects using evidence from acute pain and migraine. Eur J Pain. 2012;16(4):585–591. doi:10.1016/J.EJPAIN.2011.08.009
   PubMedGoogle Scholar
• Tanner T, Aspley S, Munn A, Thomas T. The pharmacokinetic profile of a novel fixed-dose combination tablet of ibuprofen and paracetamol. BMC Clin Pharmacol. 2010;10(1):10. doi:10.1186/1472-6904-10-10
   PubMedGoogle Scholar
• Atkinson HC. A pharmacokinetic analysis of a novel fixed dose oral combination of paracetamol and ibuprofen, with emphasis on food effect. J Bioequiv Availab. 2015;7(3). doi:10.4172/JBB.1000230
   Google Scholar
• Derry CJ, Derry S, Moore RA. Single dose oral ibuprofen plus paracetamol (Acetaminophen) for acute postoperative pain. Cochrane Database Syst Rev. 2013;2013(6). doi:10.1002/14651858.CD010210.PUB2
   Google Scholar
• Thybo KH, Hägi-Pedersen D, Dahl JB, et al. Effect of combination of paracetamol (acetaminophen) and ibuprofen vs either alone on patient-controlled morphine consumption in the first 24 hours after total hip arthroplasty: the PANSAID randomized clinical trial. JAMA. 2019;321(6):562–571. doi:10.1001/JAMA.2018.22039
   PubMed Web of Science ®Google Scholar
• Thybo KH, Hägi‐Pedersen D, Wetterslev J, et al. Benefits and harm of paracetamol and ibuprofen in combination for post-operative pain: pre-planned subgroup analyses of the multicenter, randomized PANSAID trial. Acta Anaesthesiol Scand. 2020;64(2):245–253. doi:10.1111/AAS.13496
   PubMedGoogle Scholar
• Daniels SE, Goulder MA, Aspley S, Reader S. A randomised, five-parallel-group, placebo-controlled trial comparing the efficacy and tolerability of analgesic combinations including a novel single-tablet combination of ibuprofen/paracetamol for postoperative dental pain. Pain. 2011;152(3):632–642. doi:10.1016/J.PAIN.2010.12.012
   PubMedGoogle Scholar
• Sniezek PJ, Brodland DG, Zitelli JA. A randomized controlled trial comparing acetaminophen, acetaminophen and ibuprofen, and acetaminophen and codeine for postoperative pain relief after Mohs surgery and cutaneous reconstruction. Dermatol Surg. 2011;37(7):1007–1013. doi:10.1111/J.1524-4725.2011.02022.X
   PubMedGoogle Scholar
• Mitchell A, McCrea P, Inglis K, Porter G. A randomized, controlled trial comparing acetaminophen plus ibuprofen versus acetaminophen plus codeine plus caffeine (Tylenol 3) after outpatient breast surgery. Ann Surg Oncol. 2012;19(12):3792–3800. doi:10.1245/S10434-012-2447-7
   PubMed Web of Science ®Google Scholar
• Rahme E, Barkun A, Nedjar H, Gaugris S, Watson D. Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada. Am J Gastroenterol. 2008;103(4):872–882. doi:10.1111/j.1572-0241.2008.01811.x
   PubMed Web of Science ®Google Scholar
• Mititelu Tartau L, Popa EG, Lupusoru RV, Lupusoru CE, Stoleriu I, Ochiuz L. Synergic effects of pregabalin-acetaminophen combination in somatic and visceral nociceptive reactivity. Pharmacology. 2014;93(5–6):253–259. doi:10.1159/000362649
   PubMed Web of Science ®Google Scholar
• Durmus M, But AK, Saricicek V, Toprak HI, Ersoy MO. The post-operative analgesic effects of a combination of gabapentin and paracetamol in patients undergoing abdominal hysterectomy: a randomized clinical trial. Acta Anaesthesiol Scand. 2007;51(3):299–304. doi:10.1111/J.1399-6576.2006.01237.X
   PubMedGoogle Scholar
• Johan JL, Mallet C, Shionoya K, et al. Paracetamol analogues conjugated by FAAH induce TRPV1-mediated antinociception without causing acute liver toxicity. Eur J Med Chem. 2021:213. doi:10.1016/J.EJMECH.2020.113042
   Google Scholar
• Fresno N, Pérez-Fernández R, Goicoechea C, et al. Adamantyl analogues of paracetamol as potent analgesic drugs via inhibition of TRPA1. PLoS One. 2014;9(12):e113841. doi:10.1371/journal.pone.0113841
   PubMed Web of Science ®Google Scholar
• Fricke JR, Karim R, Jordan D, Rosenthal N. A double-blind, single-dose comparison of the analgesic efficacy of tramadol/acetaminophen combination tablets, hydrocodone/acetaminophen combination tablets, and placebo after oral surgery. Clin Ther. 2002;24(6):953–968. doi:10.1016/S0149-2918(02)80010-8
   PubMedGoogle Scholar
• Macleod AG, Ashford B, Voltz M, et al. Paracetamol versus paracetamol-codeine in the treatment of post-operative dental pain: a randomized, double-blind, prospective trial. Aust Dent J. 2002;47(2):147–151. doi:10.1111/J.1834-7819.2002.TB00319.X
   PubMed Web of Science ®Google Scholar
• Smith AB, Ravikumar TS, Kamin M, Jordan D, Xiang J, Rosenthal N. Combination tramadol plus acetaminophen for postsurgical pain. Am J Surg. 2004;187(4):521–527. doi:10.1016/j.amjsurg.2003.12.038
   PubMed Web of Science ®Google Scholar
• Rawal N, Macquaire V, Catalá E, Berti M, Costa R, Wietlisbach M. Tramadol/paracetamol combination tablet for postoperative pain following ambulatory hand surgery: a double-blind, double-dummy, randomized, parallel-group trial. J Pain Res. 2011;4:103. doi:10.2147/JPR.S16760
   PubMedGoogle Scholar
• Aweke Z, Seyoum F, Shitemaw T, Doba DN. Comparison of preemptive paracetamol, paracetamol-diclofenac & paracetamol-tramadol combination on postoperative pain after elective abdominal surgery under general anesthesia, Ethiopia: a randomized control trial study, 2018. BMC Anesthesiol. 2020;20(1). doi:10.1186/S12871-020-01115-6
   PubMedGoogle Scholar
• Singh AM, Kirsch JM, Patel MS, et al. Effect of perioperative acetaminophen on pain management in patients undergoing rotator cuff repair: a prospective randomized study. J Shoulder Elb Surg. 2021;30(9):2014–2021. doi:10.1016/J.JSE.2021.03.132
   PubMedGoogle Scholar